Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma
β Scribed by P. -L. Lollini; C. Giovanni; G. Nicoletti; A. Bontadini; P. -L. Tazzari; L. Landuzzi; K. Scotlandi; P. Nanni
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 482 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0262-0898
No coin nor oath required. For personal study only.
β¦ Synopsis
The effects of recombinant tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on B16 mouse melanoma experimental metastatic ability and major histocompatibility complex (H-2b) antigens expression were studied. B16 cells exposed in vitro to TNF-alpha had an increased H-2 expression and were more metastatic than untreated cells. The simultaneous treatment with TNF-alpha and IFN-gamma amplified the enhancement of experimental metastasis and all other effects obtained with TNF-alpha alone. The B16 clone B78H1, selectively resistant to H-2 induction and to enhancement of metastatic ability by IFN-gamma, was not affected by treatment with TNF-alpha and with TNF-alpha + IFN-gamma. These findings contribute to a better understanding of the pleiotropic effects of TNF, some of which can have opposing actions in the complex tumor-host relationships.
π SIMILAR VOLUMES
## Background: Isolated limb perfusion (ilp) with tumor necrosis factor alpha (tnf alpha) +/-interferon gamma (ifn gamma) and melphalan in patients with primarily irresectable soft tissue sarcoma is promising in terms of tumor regression and limb salvage. however, the feasibility of radiotherapy in